The DRI™ Fentanyl II Assay (Thermo Fisher) is an immunoassay intended for the qualitative determination of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL.

The DRI™ Fentanyl II Assay is an immunoassay intended for the qualitative detection of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL.

DRI™ Fentanyl II Cutoff Calibrator (Thermo Fisher) is intended for use in the calibration of the DRI™ Fentanyl II Assay.

DRI™ Fentanyl II Negative Calibrator (Thermo Fisher) is intended for use in the calibration of the DRI™ Fentanyl II Assay.

DRI™ Fentanyl II Control (Thermo Fisher) is intended for use in quality control of the DRI™ Fentanyl II Assay.

The ARK™ Topiramate Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of topiramate in human serum or plasma on automated clinical chemistry analyzers. The results obtained are used in the diagnosis and treatment of topiramate overdose and in monitoring levels of topiramate to help ensure appropriate therapy.

The ARK™ Topiramate Calibrator consists of a six-level set to calibrate the ARK™ Topiramate Assay.

The ARK™ Topiramate Control consists of a three-level set used for quality control of the ARK™ Topiramate Assay.

The ARK™ Efavirenz Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of efavirenz in human serum or plasma on automated clinical chemistry analyzers.

ARK™ Efavirenz Calibrator is intended for use in calibration of the ARK™ Efavirenz Assay.

ARK™Efavirenz Control is intended for use in quality control of the ARK™Efavirenz Assay.

The ARK™ Zonisamide Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of zonisamide in human serum or plasma on automated clinical chemistry analyzers. Zonisamide concentrations can be used as an aid in management of patients treated with zonisamide. The ARK™ Zonisamide Assay consists of reagents RI anti-zonisamide polyclonal antibody with substrate and R2 zonisamide epitope labeled with bacterial G6PDH enzyme.

The ARK™ Zonisamide Calibrator is intended for use in calibration of the ARK™ Zonisamide Assay. .

The ARK™ Zonisamide Control is intended for use in quality control of the ARK™Zonisamide Assay.

The ARK™ Lamotrigine Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of Lamotrigine in human serum or plasma on automated clinical chemistry analyzers. Lamotrigine concentrations can be used as an aid in management of patients treated with Lamotrigine. The ARK™ Lamotrigine Assay consists of reagents RI anti-Lamotrigine polyclonal antibody with substrate and R2 Lamotrigine epitope labeled with bacterial G6PDH enzyme.

The ARK™ Lamotrigine Calibrator is intended for use in calibration of the ARK™ Lamotrigine Assay.

The ARK™ Lamotrigine Control is intended for use in quality control of the ARK™Lamotrigine Assay.

The ARK™ Levetiracetam Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of Levetiracetam in human serum or plasma on automated clinical chemistry analyzers. Levetiracetam concentrations can be used as an aid in management of patients treated with Levetiracetam. The ARK™ Levetiracetam Assay consists of reagents RI anti-Levetiracetam polyclonal antibody with substrate and R2 Levetiracetam epitope labeled with bacterial G6PDH enzyme.

The ARK™ Levetiracetam Calibrator is intended for use in calibration of the ARK™ Levetiracetam Assay.

The ARK™ Levetiracetam Control is intended for use in quality control of the ARK™Levetiracetam Assay.

The ARK™ Gabapentin Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of gabapentin in human serum or plasma on automated clinical chemistry analyzers. Gabapentin concentrations can be used as an aid in management of patients treated with gabapentin.

The ARK™ Gabapentin Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of gabapentin in human serum or plasma on automated clinical chemistry analyzers. Gabapentin concentrations can be used as an aid in management of patients treated with gabapentin.

The ARK™ Gabapentin Calibrator is intended for use in calibration of the ARK™ Gabapentin Assay.

The ARK™ Gabapentin Control is intended for use in quality control of the ARK™Gabapentin Assay.

The ARK Methotrexate Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of methotrexate in human serum or plasma on automated clinical chemistry analyzers.

The ARK Methotrexate Assay (non c-Pack format) is a homogeneous enzyme immunoassay intended for the quantitative determination of methotrexate in human serum or plasma on automated clinical chemistry analyzers.

The ARK Methotrexate Assay c-Pack is a homogeneous enzyme immunoassay intended for the quantitative determination of methotrexate in human serum or plasma on automated clinical chemistry analyzers.

The ARK Methotrexate Assay c-Pack (cobas c pack green reagent packs) is a homogeneous enzyme immunoassay intended for the quantitative determination of methotrexate in human serum or plasma on automated clinical chemistry analyzers.

The ARK™ Methotrexate Calibrator consists of a six-level set to calibrate the ARK™ Methotrexate Assay. The calibrators consist of a synthetic protein matrix and the levels are 0.00 umol/L, 0.05 umol/L, 0.15 umol/L, 0.25 umol/L, 0.50 umol/L and 1.2 umol/L.

The ARK™ Methotrexate Control consists of a six-level set used for quality control of the assay (tri-level calibration range set and tri-level high range set). The controls consist of a synthetic protein matrix and the levels are 0.07 umol/L, 0.40 umol/L, 0.80umol/L, 5 umol/L, 50 umol/L and 500 umol/L.

The ARK™ Methotrexate Control consists of a three-level set used for quality control of the assay (tri-level calibration range set). The controls consist of a synthetic protein matrix and the levels are 0.07 umol/L, 0.40 umol/L and 0.80umol/L.

The ARK™ Methotrexate Control consists of a three-level set used for quality control of the assay (tri-level high range set). The controls consist of a synthetic protein matrix and the levels are 5 umol/L, 50 umol/L and 500 umol/L.)

The ARK™ Methotrexate Control consists of a three-level set used for quality control of the assay (tri-level calibration range set). The controls consist of a synthetic protein matrix and the levels are 0.07 umol/L, 0.40 umol/L and 0.80umol/L.

The ARK™ Methotrexate Dilution Buffer is intended for dilution of specimens containing high concentrations of methotrexate for the ARK™ Methotrexate Assay. Its composition is equivalent to the Calibrator A (zero) of ARK™ Methotrexate Calibrator 5026-0002-00.

The ARK™ Voriconazole II Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of voriconazole in human serum on automated clinical chemistry analyzers.

ARK™ Voriconazole II Calibrator is intended for use in calibration of the ARK™ Voriconazole II Assay

ARK™ Voriconazole II Control is intended for use in quality control of the ARK™ Voriconazole II Assay.

The ARK™ Oxcarbazepine Metabolite Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of Oxcarbazepine Metabolite in human serum on automated clinical chemistry analyzers. The measurements obtained are used in monitoring levels of Oxcarbazepine Metabolite to help ensure appropriate therapy.

The ARK™ Oxcarbazepine Metabolite Calibrator is intended for use in calibration of the ARK™ Oxcarbazepine Metabolite Assay.

The ARK™ Oxcarbazepine Metabolite Control is an assayed quality control material intended for use in quality control of the ARK™ Oxcarbazepine Metabolite Assay.

The ARK™ Lacosamide Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of lacosamide in human serum on automated clinical chemistry analyzers. The measurements obtained are used in monitoring levels of lacosamide to help ensure appropriate therapy.

The ARK™ Lacosamide Calibrator is intended for use in calibration of the ARK™ Lacosamide Assay.

The ARK™ Lacosamide Control is intended for use in quality control of the ARK™ Lacosamide Assay.

The ARK™ Pregabalin Urine Assay is a homogeneous enzyme immunoassay intended for the quantitative and/or semi-quantitative analysis of pregabalin in human urine.

ARK™ Pregabalin Urine Calibrator is intended for use in calibration of the ARK™ Pregabalin Urine Assay.

ARK™Pregabalin Urine Control is intended for use in quality control of the ARK™Pregabalin Urine Assay.

The ARK™ Fentanyl II Assay is an immunoassay intended for the qualitative determination of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL.

The ARK™ Fentanyl II Assay is an immunoassay intended for the qualitative detection of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL.

The ARK™ Fentanyl II Assay is an immunoassay intended for the qualitative determination of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL.

The ARK™ Fentanyl II Assay is a homogeneous enzyme immunoassay intended for the qualitative determination of fentanyl in human urine at a cutoff concentration of 0.5 ng/mL. The assay provides a simple and rapid analytical screening procedure for detecting fentanyl in urine on automated clinical chemistry analyzers.